Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Power Versus Temperature Controlled Ablation for Treatment of VT

A legfontosabb adatok

Ki végzi
University Hospitals Coventry and Warwickshire NHS Trust
Hol
Egyesült Királyság2 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
61 fő vett részt
Kezdés
2022. szept. 26.
Befejezés
2025. nov. 21.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Temperature controlled DiamondTemp (DT) ablation catheter
  • Tacticath/Tactiflex (TF) ablation catheter
A regiszteradat frissítve
2026. április 14.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 17 feltétel megnézéseKevesebb

Ki vehet részt

  • ≥ 18 years of age to give informed consent specific to national legal requirements
  • Subject with 1 of the following:; Symptomatic VT (despite optimal medical therapy), 3 or more episodes of VT within 24 h (VT storm); At least 3 episodes of VT requiring anti-tachycardia pacing (ATP); At least one appropriate ICD shock
  • Referred for VT ablation by Consultant Electrophysiologist
  • Subject discussed at cardiac EP MDT
  • Suitable candidate for intra-cardiac mapping and ablation of arrhythmia
  • Subject agrees to comply with study procedures and be available for routine follow up visits for at least 12 months after enrolment
  • Subject is willing and able to provide written consent

Ki nem vehet részt

  • Sepsis, active systemic infection or fever (>100.5 F/38 C) within a week prior to the ablation procedure
  • Known allergies or intolerance to anticoagulant and antiplatelet therapies to be used in conjunction with the study or contrast sensitivity that can't be adequately pre-treated prior to the ablation procedure
  • Enrolment in a concurrent clinical study that in the judgement of the investigator would increase risk to the subject or deem the subject inappropriate to participate in the study
  • Coagulopathy, bleeding diathesis or suspected pro-coagulant state
  • Significant restrictive or obstructive pulmonary disease or chronic respiratory condition
  • Renal failure requiring dialysis or renal compromise that in the investigators judgement would increase risk to the subject or deem the subject inappropriate to participate in the study
  • BMI >40kg/m2
  • Presence of intramural thrombus, tumour or abnormality that precludes vascular access, catheter introduction or manipulations
  • Positive pregnancy test results for female subjects of childbearing or potential or breast feeding
  • Significant GI bleed

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Ventricular Tachycardia (VT) is a life threatening heart rhythm that comes from the bottom chambers of the heart (the ventricles) and is a leading cause of sudden cardiac death.

A teljes eredeti leírásKevesebb

The majority of patients that are at risk of VT or suffer a cardiac arrest will have an Internal Cardiac Defibrillator (ICD) in situ to treat the abnormal heart rhythm. The ICD can deliver a painful shock to restore normal heart rhythm but importantly does not treat the underlying cause. Current treatment for the prevention of recurrent VT include catheter ablation (CA) or medication. Long-term results with global 12 month VT-free survival rates with CA are around 50%.

The trial is to compare 2 different types of ablation catheter that are used to cauterise small areas of unhealthy tissue within the heart that are responsible for VT: Diamond Temp (DT) and Tacticath/Tactiflex (TF). Our hypothesis is that the DT ablation catheter will provide comparable efficacy and safety for the treatment of VT as the current industry gold standard (TF).

A vizsgálat 2 csoportja

  • Temperature controlled DiamondTemp (DT) ablation catheterEgyéb csoport

    Intervention arm

  • Power controlled Tacticath/Tactiflex ablation catheterEgyéb csoport

    Control arm

    Kezelés: Tacticath/Tactiflex (TF) ablation catheter

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Randomised Control Trial of Power Versus Temperature-controlled Irrigated Radiofrequency Ablation for the Treatment of Ventricular Tachycardia (VT)
A regiszteradat frissítve
2026. április 14.